185 related articles for article (PubMed ID: 32334327)
1. Development of a β-HPV vaccine: Updates on an emerging frontier of skin cancer prevention.
Gupta R; Rady PL; Doan HQ; Tyring SK
J Clin Virol; 2020 May; 126():104348. PubMed ID: 32334327
[TBL] [Abstract][Full Text] [Related]
2. HPV vaccination for prevention of skin cancer.
Vinzón SE; Rösl F
Hum Vaccin Immunother; 2015; 11(2):353-7. PubMed ID: 25692212
[TBL] [Abstract][Full Text] [Related]
3. Human papillomaviruses and non-melanoma skin cancer.
McLaughlin-Drubin ME
Semin Oncol; 2015 Apr; 42(2):284-90. PubMed ID: 25843732
[TBL] [Abstract][Full Text] [Related]
4. Association of Human Papillomavirus Vaccine With the Development of Keratinocyte Carcinomas.
Nichols AJ; Allen AH; Shareef S; Badiavas EV; Kirsner RS; Ioannides T
JAMA Dermatol; 2017 Jun; 153(6):571-574. PubMed ID: 28196178
[TBL] [Abstract][Full Text] [Related]
5. Potential mechanisms for HPV vaccine-induced long-term protection.
Stanley M
Gynecol Oncol; 2010 Jun; 118(1 Suppl):S2-7. PubMed ID: 20494220
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous HPV and skin cancer.
Accardi R; Gheit T
Presse Med; 2014 Dec; 43(12 Pt 2):e435-43. PubMed ID: 25451638
[TBL] [Abstract][Full Text] [Related]
7. Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.
Connolly K; Manders P; Earls P; Epstein RJ
Cancer Treat Rev; 2014 Mar; 40(2):205-14. PubMed ID: 24051018
[TBL] [Abstract][Full Text] [Related]
8. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
9. Developments in L2-based human papillomavirus (HPV) vaccines.
Schellenbacher C; Roden RBS; Kirnbauer R
Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous alpha, beta and gamma human papillomaviruses in relation to squamous cell carcinoma of the skin: a population-based study.
Farzan SF; Waterboer T; Gui J; Nelson HH; Li Z; Michael KM; Perry AE; Spencer SK; Demidenko E; Green AC; Pawlita M; Karagas MR
Int J Cancer; 2013 Oct; 133(7):1713-20. PubMed ID: 23536363
[TBL] [Abstract][Full Text] [Related]
11. Serological association of beta and gamma human papillomaviruses with squamous cell carcinoma of the skin.
Waterboer T; Abeni D; Sampogna F; Rother A; Masini C; Sehr P; Michael KM; Pawlita M
Br J Dermatol; 2008 Aug; 159(2):457-9. PubMed ID: 18503604
[TBL] [Abstract][Full Text] [Related]
12. Immunity to commensal papillomaviruses protects against skin cancer.
Strickley JD; Messerschmidt JL; Awad ME; Li T; Hasegawa T; Ha DT; Nabeta HW; Bevins PA; Ngo KH; Asgari MM; Nazarian RM; Neel VA; Jenson AB; Joh J; Demehri S
Nature; 2019 Nov; 575(7783):519-522. PubMed ID: 31666702
[TBL] [Abstract][Full Text] [Related]
13. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
14. From the monovalent to the nine-valent HPV vaccine.
Pils S; Joura EA
Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetrance.
Venuti A; Lohse S; Tommasino M; Smola S
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180287. PubMed ID: 30955489
[TBL] [Abstract][Full Text] [Related]
16. Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model.
Vinzón SE; Braspenning-Wesch I; Müller M; Geissler EK; Nindl I; Gröne HJ; Schäfer K; Rösl F
PLoS Pathog; 2014 Feb; 10(2):e1003924. PubMed ID: 24586150
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous Human Papillomaviruses and the Risk of Keratinocyte Carcinomas.
Rollison DE; Amorrortu RP; Zhao Y; Messina JL; Schell MJ; Fenske NA; Cherpelis BS; Giuliano AR; Sondak VK; Pawlita M; McKay-Chopin S; Gheit T; Waterboer T; Tommasino M
Cancer Res; 2021 Sep; 81(17):4628-4638. PubMed ID: 34266893
[TBL] [Abstract][Full Text] [Related]
18. Measuring serum antibody to human papillomavirus following infection or vaccination.
Frazer IH
Gynecol Oncol; 2010 Jun; 118(1 Suppl):S8-11. PubMed ID: 20494221
[TBL] [Abstract][Full Text] [Related]
19. Vaccines against human papillomaviruses--a major breakthrough in cancer prevention.
Vonka V; Hamsíková E
Cent Eur J Public Health; 2007 Dec; 15(4):131-9. PubMed ID: 18251226
[TBL] [Abstract][Full Text] [Related]
20. Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?
Yadav R; Zhai L; Tumban E
Viruses; 2019 Dec; 12(1):. PubMed ID: 31877975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
